(Bloomberg) -- Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, though fewer-than-expected cases in a study made it hard to determine how well ...
The aim of the study is to understand if the combination of the vaccines is safe, and the immune response after adding the ...
Hosted on MSN
Study Suggests Possible Link Between Pfizer COVID-19 Vaccine and Vision-Related Eye Conditions
Public interest has recently turned to the human eye and the Pfizer COVID-19 Vaccine. Two peer-reviewed papers have helped drive the latest debate. One Turkish cohort measured the cornea before and ...
Prime Minister Jacinda Ardern announced the strategy Monday, saying the decision was based on the Pfizer vaccine's ...
(NEXSTAR) – The Pfizer/BioNTech vaccine may be less effective against the South African strain of the coronavirus than other variations circulating in the population, a new study out of Israel has ...
Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. Pfizer Inc. (PFE) is running a Phase 3 trial titled “A Phase 3, Randomized Double-Blind Trial to ...
Add Yahoo as a preferred source to see more of our stories on Google. Pfizer Inc. signage is seen on July 22, 2020 in New York City. (Jeenah Moon via Getty Images) This story was originally published ...
The study also reviews the great potential of mRNA vaccines to treat influenza, RSV, cancer, and autoimmune diseases.
Pfizer Inc announced an update on their ongoing clinical study. TipRanks Welcomes a New ETF – NYSE:RANK. TipRanks has entered a new arena in the investing world, powering the in ...
Four doses of an experimental vaccine to protect against Lyme disease reduced the number of tick-borne infections by more than 70 percent, according to Pfizer and Valneva, the pharmaceutical companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results